Glasgow Molecular Pathology Node

12:00-13:00

Registration, lunch, networking, posters, exhibitors

13.00-13:05

Welcome

Professor Dame Anna Dominiczak, Vice-Principal and Head of College of Medical, Veterinary and Life Sciences, University of Glasgow

13:05-13:25

Glasgow Molecular Pathology Node

Dr Karin Oien, Director Glasgow Molecular Pathology Node, University of Glasgow

13:25-13:45

The Molecular Pathology Node Training Workstrand

Professor Ed Tobias, Professor of Genetic Medicine, University of Glasgow

13:45-14:05

Cost Reduction and Patient Improvement Using Pharmacogenomics and Expert Pharmacy Review

Dr Jami Elliot, Director of Clinical Business Development, Thermo Fisher Scientific

14:05-14:30

EpiSwitch Technology: 3D Genetics and Its Potential for Clinical Insights

Dr Ewan Hunter, Senior Vice President, Oxford Biodynamics

14:30-15:00

Coffee and networking

15:00-15:20

Congenica

Dr Nick Lench, Chief Scientific Officer, Congenica Ltd

15:20-15:40

Cell of Origin Project

Dr John Goodlad, Consultant Haematopathologist, NHS GG&C; Nicola Williams, Consultant Clinical Scientist, NHS GG&C

15:40-16:00

Presenting on his work in Digital Pathology and iCAIRD Projects

Dr Peter Caie, Senior Research Fellow, University of St Andrews

16:00-16:20

Strategies to implement an optimized, evidence-based workflow for the processing of biospecimen to improve NGS outcomes

Eberhard Haefele, Innovation Manager, Leica Biosystems; Dr Karin Oien, Director, Glasgow Molecular Pathology Node; Dr Jennifer Hay, Lab Manager, NHS GG&C

16:20-16:40

Summary and Close

Professor Tony Freemont, Director MMPathIC, University of Manchester